Skip to main content
NVO
NYSE Life Sciences

Novo Nordisk Inks $1.3B Deal for Nanexa's Drug-Delivery Tech

Tom Rudovsky · Reported by Seeking Alpha
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$38.64
Mkt Cap
$170.245B
52W Low
$35.12
52W High
$64.16
52W Position info
10% above low
Off High info
40% below high
Rel. Volume info
1.6× avg
Market data snapshot near publication time

NVO is trading near its 52-week low of $35.12 (10% above the low).

Summary

Novo Nordisk signed a deal worth up to $1.3B with Swedish drug-delivery company Nanexa for exclusive access to its PharmaShell technology. The agreement covers up to five development programs targeting obesity, type 2 diabetes, and other cardiometabolic diseases, with monthly and quarterly dosing options. Nanexa receives €615M in upfront and milestone payments, plus low single-digit royalties. This expands Novo's pipeline capabilities in its core therapeutic areas and follows a $1.4B partnership with Orbis Medicine announced earlier this month. The deal adds a new technology platform but is modest relative to Novo's market cap; near-term financial impact is limited to milestone payments.

At the time of this announcement, NVO was trading at $38.64 on NYSE in the Life Sciences sector, with a market capitalization of approximately $170.2B. The 52-week trading range was $35.12 to $64.16. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Seeking Alpha.


Price Chart

Share this article

Copied!

NVO - Latest Insights

NVO
Nov 04, 2026, 8:35 AM EST
Source: Benzinga
Importance Score:
8
Price at Filing: $42.91
Real-time Price: $39.44 info
Change: -$3.47 (-8%) info
Market Cap: $179.28B info
NVO
Nov 04, 2026, 7:47 AM EST
Filing Type: 6-K
Importance Score:
9
Price at Filing: $42.90
Real-time Price: $39.44 info
Change: -$3.46 (-8%) info
Market Cap: $179.28B info
NVO
Nov 04, 2026, 4:00 AM EST
Source: Seeking Alpha
Importance Score:
9
Price at Filing: $41.96
Real-time Price: $39.44 info
Change: -$2.52 (-6%) info
Market Cap: $179.28B info
NVO
Oct 27, 2026, 3:10 AM EDT
Source: Seeking Alpha
Importance Score:
7
Price at Filing: $39.16
Real-time Price: $39.44 info
Change: +$0.280 (+0.72%) info
Market Cap: $179.28B info
NVO
Oct 02, 2026, 5:53 PM EDT
Filing Type: 6-K
Importance Score:
8
Price at Filing: $36.88
Real-time Price: $39.44 info
Change: +$2.56 (+7%) info
Market Cap: $179.28B info